2 deals
Ceretas triggers final $490,000 grant tranche as dementia device prototypes clear review
Australian medtech Ceretas hit a milestone in its CUREator+ program, unlocking the final instalment of a government-funded grant; the piece also recaps its A$8 million IPO and ASX listing earlier in 2026.